Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Buecher

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Cancer Medicine|May 28, 2018
Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrencesWulfran Cacheux, Petros Tsantoulis, Adrien Briaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell CarcinomaLuc Cabel, Emmanuelle Jeannot, Ivan Bieche, et al.
Journal of Medical Genetics|May 28, 2013
CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre studyPatrick R Benusiglio, David Malka, Etienne Rouleau, et al.
Journal of Medical Genetics|May 31, 2015
Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutationPatrick R Benusiglio, Chystelle Colas, Etienne Rouleau, et al.
Oncotarget|February 9, 2018
Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinomaWulfran Cacheux, Virginie Dangles-Marie, Etienne Rouleau, et al.
Plos One|September 26, 2015
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2Sophie Blein, Laure Barjhoux, , et al.
Clinical Genetics|March 28, 2023
Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus bloodMathias Schwartz, Virginie Moncoutier, Adrien Peytral, et al.
European Journal of Human Genetics : EJHG|May 13, 2026
Follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: Data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.
European Journal of Human Genetics : EJHG|December 20, 2017
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancersLisa Golmard, Laurent Castéra, Sophie Krieger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2018
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 TrialAlice Bernard-Tessier, Emmanuelle Jeannot, David Guenat, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Cancer Medicine|May 28, 2018
Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrencesWulfran Cacheux, Petros Tsantoulis, Adrien Briaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell CarcinomaLuc Cabel, Emmanuelle Jeannot, Ivan Bieche, et al.
Journal of Medical Genetics|May 28, 2013
CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre studyPatrick R Benusiglio, David Malka, Etienne Rouleau, et al.
Journal of Medical Genetics|May 31, 2015
Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutationPatrick R Benusiglio, Chystelle Colas, Etienne Rouleau, et al.
Oncotarget|February 9, 2018
Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinomaWulfran Cacheux, Virginie Dangles-Marie, Etienne Rouleau, et al.
Plos One|September 26, 2015
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2Sophie Blein, Laure Barjhoux, , et al.
Clinical Genetics|March 28, 2023
Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus bloodMathias Schwartz, Virginie Moncoutier, Adrien Peytral, et al.
European Journal of Human Genetics : EJHG|May 13, 2026
Follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: Data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.
European Journal of Human Genetics : EJHG|December 20, 2017
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancersLisa Golmard, Laurent Castéra, Sophie Krieger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2018
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 TrialAlice Bernard-Tessier, Emmanuelle Jeannot, David Guenat, et al.
Pageof 12